International Society for the Study of Women's Sexual Health

ISSWSH is a multidisciplinary, academic, and scientific organization whose purposes are:

To provide

opportunities for communication among scholars, researchers, and practitioners about women's sexual function and sexual experience...

To support

the highest standards of ethics and professionalism in research, education, and clinical practice of women's sexuality, and ...

To provide

the public with accurate information about women's sexuality and sexual health.

UPCOMING MEETING

ISSWSH Fall Course 2018

November 15-17, 2018   114 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019

March 7-10, 2019   226 days left
Atlanta, GA, USA

LATEST NEWS

Management of GSM in Women with a High Risk for Cancer: Consensus Recommendation

ISSWSH in collaboration with the North American Menopause Society (NAMS) is publishing consensus recommendations for the management of genitourinary syndrome of menopause in women with or at high risk for breast cancer. The consensus recommendations will assist healthcare providers in managing GSM with a goal of improving the care and quality of life for these women. Genitourinary syndrome of menopause is more prevalent in survivors of breast cancer, is commonly undiagnosed and untreated, and may have early onset because of cancer treatments or risk-reducing strategies.

Read the Full Article

DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

ISSWSH PUBLICATION ON PROCESS OF CARE FOR HSDD NOW AVAILABLE IN MAYO CLINIC PROCEEDINGS

The International Society for the Study of Women’s Sexual Health (ISSWSH) is pleased to announce the publication of its Process of Care for Management of Hypoactive Sexual Desire Disorder (HSDD) in Women in Mayo Clinic Proceedings.  This milestone publication is the first to provide a consensus clinical management algorithm for the diagnosis and treatment of HSDD.

HSDD is a medical condition characterized by decreased or absent spontaneous or responsive sexual desire (i.e., sexual thoughts or fantasies) associated with negative emotional states and personal distress.  Women with HSDD experience increased healthcare costs, health burden, and decreased quality of life.  HSDD is the most common sexual dysfunction in women and studies in the US and Europe estimate its prevalence to be 6 – 19%.  Recent research and increasing public awareness of HSDD will increase the number of women seeking treatment from healthcare professionals.  The Process of Care for HSDD was developed to meet this unmet need.

Developed by 17 international expert panelists representing multiple healthcare disciplines and clinical specialties, the ISSWSH Process of Care for HSDD in Women provides evidence-based guidelines for the identification, diagnosis and treatment of this disorder in women that can be followed by non-expert primary care professionals and sexual medicine experts alike.  The Process of Care algorithm emphasizes biopsychosocial assessment and education, highlights opportunities to address modifiable factors, includes patient needs and preferences in the decision-making process, delineates evidence-based treatment options informed by reproductive status, and defines situations for specialized referral.  A separate ISSWSH panel of experts previously published a consensus white paper review on the epidemiology, nomenclature, pathophysiology and treatment strategies for HSDD for non-sexual medicine experts in Mayo Clinic Proceedings.

ISSWSH is a not-for-profit multidisciplinary, academic and scientific organization dedicated to supporting the highest standards of ethics and professionalism in research, education, and clinical practice of women's sexual health.  More information about the society and its activities can be obtained at:  http://www.isswsh.org.

Funding for the development of this Process of Care was provided by ISSWSH through unrestricted educational grants from Valeant Pharmaceuticals International, Inc, AMAG Pharmaceuticals, Emotional Brain BV, and Palatin Technologies, Inc.  The process of care algorithm was wholly developed under the auspices of ISSWSH with no participation or influence from industry.

Latest Tweets

Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource https://t.co/Q043F2YJOm. Encourag… https://t.co/6vDWxSzXvL ISSWSH
Pelvic exam is essential to the accurate diagnosis and treatment of #FSD, but it has a complicated history https://t.co/YTOy3eSbtJ ISSWSH
Check out these great books focusing on women's sexuality and #sexualhealth @ISSWSH https://t.co/gh0S07A5uk ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.